Breathing in chemo: new hope for lung metastases?
NCT ID NCT03093909
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This early-phase study tests a chemotherapy drug (gemcitabine) given as a mist to breathe in. It is for people whose solid tumors have spread to the lungs and who have no standard treatment options. The main goal is to find the safest dose and watch for side effects. Up to 44 participants will take part at MD Anderson.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM OF BONE AND ARTICULAR CARTILAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could an oral drug boost immunotherapy in tough melanoma cases?
- Can avastin stop ovarian cancer from coming back?
- Head-to-Head drug battle for rare kidney cancer
- New combo targets Hard-to-Treat melanoma
- Can yoga ease the burden of head and neck cancer treatment?
- Bacteria bombs target stubborn tumors in new cancer combo trial